Plasma Cell Acid Phosphatase and Prognosis in Multiple Myeloma

References

• Li C. Y., Yam L. T., Lam K. W. Acid phosphatase isoenzymes in human leucocytes in normal and pathologic conditions. J. Histochem. Cytochem. 1970; 18: 473–481
   PubMed Web of Science ®Google Scholar
• Li C. Y., Yam L. T., Lam K. W. Studies of acid phosphatase isoenzymes in human leucocytes. Demonstration of isoenzyme cell specificity. J. Histochem. Cytochem. 1970; 18: 901–910
   PubMed Web of Science ®Google Scholar
• Lafuente R., Woessner S., Sans-Sabrafen J. Iso-enzymatyc study of leucocyte acid phosphatase in haematologic diagnosis. Scand. J. Haematol. 1979; 23: 146–151
   PubMedGoogle Scholar
• Loffler H., Schubert J. C. F. Cytochemische un-terschiede zuischen plasmazellen und myeiomzellen. Klin. Wochenschr. 1963; 41: 484–488
   Google Scholar
• Loffler H. Unspezifische esterasen und saure phosphatase bei plasmozytomen. Blut 1967; 15: 330–335
   PubMedGoogle Scholar
• Aparisi T., Arborgh B., Ericsson L. E. Giant cell tumors of bone: fine structural localization of acid phosphatase. Virch. Arch. Pathol. Anat. 1977; 376: 299–304
   PubMed Web of Science ®Google Scholar
• Miedema E. D. Protein catabolism and acid phosphatase activity in mixed normal and neoplastic human cell culture. J. Natl. Cancer Inst. 1969; 42: 135–140
   PubMed Web of Science ®Google Scholar
• Brightwell R., Tappel A. L. Lysosomal acid pyrophosphatase and acid phosphatase. Arch. Biochem. Bio-phys. 1968; 123: 333–339
   Web of Science ®Google Scholar
• Tortarolo M., Cantore N., Grande A., Buonanno G., Dammacco F. Plasma cell acid phosphatase as an adjunct in the differential diagnosis of monoclonal immunoglob-ulinemias. Acta Haematol. 1981; 65: 103–107
   PubMed Web of Science ®Google Scholar
• Hirschom R., Weissmann G. Death of leucocytes due to the ingestion of heterologous lysosomes. Nature 1967; 214: 892–897
   PubMed Web of Science ®Google Scholar
• Santus G., Pirali F., Inzoli M. R. Utilita della fosfatasi acida plasmacellulare nella diagnostica differenziale delle gammopatie monoclonali. Minerva Med. 1981; 72: 2479–2483
   PubMedGoogle Scholar
• Ricci C., Coscia G. G., Bellone G., Novarini M., Dis-Calzi G. L., Cascio G. Zytologische untersuchung der sauren phosphataseaktivitat in den plasmazeller bei mon-oklonalen gammopathien. Acta Med. Austriaca 1984; 11: 37–41
   PubMedGoogle Scholar
• Cassuto J. P., Hammou J., C Pastorelli E., Dujardin P., Masseyeff R. Plasma cell acid phosphatase, a discriminative test for benign and malignant monoclonal gam-mopathies. Biomedicine 1977; 27: 197–199
   PubMedGoogle Scholar
• Miliani A., Anichini P., Di Guglielmo R., Pellegrini G., Firorelli C., Cuccuini A., Cozzolino F., Vercelli D. Etude cyto-enzimologique des plasmocytes medullaires des dysglobulinemies monoclonales myelomateuses et non myelomateuses. Nouv. Rev. Fr. Hematol. 1982; 24: 27–33
   PubMedGoogle Scholar
• Bataille R., Durie B. G. M., Sany J., Salmon S. E. Myeloma bone marrow acid phosphatase staining: a currelative study of 38 patients. Blood 1980; 55: 802–805
   PubMed Web of Science ®Google Scholar
• Hoffman J. J. M.L., Breed W. P. M., Swaak-Lammers N. Plasma cell acid phosphatase score in multiple myeloma and related disorders. Br. J. Haematol. 1985; 59: 67–72
   PubMed Web of Science ®Google Scholar
• Musto P., Barbieri D., Gennari M., Spanedda R., Sca-Poli G., Castoldi G. Significato biologico e clin-ico della fosfatasi acida plasmacellulare nel mieloma multiple. Rec. Progr. Med. 1986; 11: 452–457
   Google Scholar
• Geniram A., Fiorini G., Spotti G. Discrasie plasmacellulari benigne e maligne: metodi di indagine. Hae-matologica 1984; 69: 163–169
   PubMedGoogle Scholar
• Johansen P., Krogh Jensen M. Enzyme cytochemistry and immunohistochemistry in monoclonal gam-mopathy and reactive plasmocytosis. Acta Pathol. Microbiol. Scand. 1980; 88: 377–382
   Google Scholar
• Portero J. A., Martin S., Gonzalez M., San Miguel J. F. Cytochemistry in the differential diagnosis of monoclonal gammopathies. Br. J. Haematol. 1985; 60: 768, letter
   PubMed Web of Science ®Google Scholar
• Saeed S. M., Stock-Novak D., Pohlod R., Crowley J., Salmon S. E. Prognostic correlation of plasma cell acid phosphatase and beta-glicuronidase in multiple myeloma: a Southwest Oncology Group study. Blood 1991; 78: 3281–3287
   PubMed Web of Science ®Google Scholar
• Boccadoro M., Gallamini A., Fruttero A., Gavarotti P., Fossati G., Redoglia V., Buffa F., Pileri A. Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma: relationship to the thymidine-labelling index. J. Clin. Oncol. 1985; 3: 1503–1508
   PubMed Web of Science ®Google Scholar
• Musto P. Plasma cell acid phosphatase in multiple myeloma. Blood 1993; 81: 869, letter
   PubMed Web of Science ®Google Scholar
• Durie B. G. M., Salmon S. E. Clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36: 842–854
   PubMed Web of Science ®Google Scholar
• Kyle R. A. Monoclonal gammopathy of undetermined significance: natural history in 241 cases. Am. J. Med. 1978; 64: 814–826
   PubMed Web of Science ®Google Scholar
• Kyle R. A., Greip P. R. Smoldering multiple myeloma. N. Engl. J. Med. 1980; 302: 1347–1349
   PubMed Web of Science ®Google Scholar
• Gerdes J., Schwab U., Lemke H., Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 1983; 31: 13–20
   PubMed Web of Science ®Google Scholar
• Linn S. C., Giaccone G., van Kalken C. K., Pinedo H. M. P-glycoprotein mediated multidrug resistance and its clinical relevance in cancer treatment. Forum 1992; 6: 642–657
   Google Scholar
• Musto P., Bavaro P., Cascavilla N., Melillo L., No-Bile M. Tecniche immunoenzimatiche di caratteriz-zazione cellulare: particolari possibilita' applicative nella ci-tologia onco-ematologica. Medicina 1987; 7: 38–42
   Google Scholar
• Musto P., Lombardi G., Matera R., Carotenuto M. The expression of the multidrug transporter P-170 glycoprotein in remission phase is associated with early and resistant relapse in multiple myeloma. Haematologica 1991; 76: 513–516
   PubMedGoogle Scholar
• Barka T., Anderson P. J. Histochemical methods for acid phosphatase using hexazonium pararosanilin as coupler. J. Histochem. Cytochem. 1962; 10: 741–753
   Web of Science ®Google Scholar
• Boccadoro M., Marmont F., Tribalto M., Avvisati G., Andriani A., Barbui T., Cantonetti M., Carotenuto M., Comotti B., Dammacco F., Frieri R., Gallamini A., Gallone G., Giovangrossi P., Grignani F., Lauta V. M., Lib-Erati M., Musto P., Neretto G., Petrucci M. T., Resegotti L., Pileri A., Mandelli F. Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high risk patients. J. Clin. Oncol. 1991; 9: 444–448
   PubMed Web of Science ®Google Scholar
• Musto P., Bodenizza C., Matera R., Lombardi G., Mo-Relli A., Sajeva M. R., Carotenuto M. (1989) Immu-nocytochemical detection of growth fraction in plasma cell neoplasia by means of Ki-67 monoclonal antibody. Paper presented at the Int. Conf. on Multiple Myeloma, Bologna, June, 19–221989, 183, Abstract
   Google Scholar
• Bataille R., Boccadoro M., Klein B., Durie B. G. M., Pileri A. C-reactive protein and serum beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood 1992; 80: 733–737
   PubMed Web of Science ®Google Scholar
• Brown R. D., Joshua D. E., Nelson M., Gibson J., Dunn J., Mac Lennan I. C. M. Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma: results from the MRC (UK) V trial. Br. J. Haematol. 1993; 84: 238–241
   PubMed Web of Science ®Google Scholar
• Dimopoulos M. A., Barlogie B., Smith T. L., Alex-Anian R. High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma 1991. Ann. Intern. Med. 1991; 115: 931–935
   PubMed Web of Science ®Google Scholar
• Musto P., Cascavilla N., Di Renzo N., Ladogana S., La Sala A., Melillo L., Nobile M., Matera R., Lombardi G., Carotenuto M. Clinical relevance of immunocy-tochemical detection of multidrug associated P-glycoprotein in hematological malignancies. Tumori 1990; 76: 753–759
   Google Scholar
• Jacobs P., Kinnear B., Richards J. D. M. Diagnostic significance of “flaming” plasma cells in multiple myeloma. Lancet 1980; ii: 363–364
   Google Scholar
• Hayhoe F. G. J., Neuman Z. Cytology of myeloma cells. J. Clin. Pathol. 1976; 29: 916–922
   PubMed Web of Science ®Google Scholar
• Musto P., Fusilli S., Salcuni G., Bodenizza C., Falcone A., Bisceglia M., Attino V., Carotenuto M. (1993) Morphometric studies in multiple myeloma: preliminar data. Paper presented at the XXXIV Congress of the Italian Society of Hematology., Naples, October, 5–81993, 107, Abstract
   Google Scholar
• Saeed B. M., Stock-Novack D., Pohlod R., Crowley J., Salmon S. E. Plasma cell acid phosphatase in multiple myeloma. Blood 1993; 81: 870, response
   Web of Science ®Google Scholar